Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
Natàlia Casamitjana, Marc Corbacho-Monné, María Ubals, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e4073-e4081
Open Access | Times Cited: 278

Showing 1-25 of 278 citing articles:

Mild or Moderate Covid-19
Rajesh T. Gandhi, John B. Lynch, Carlos del Rı́o
New England Journal of Medicine (2020) Vol. 383, Iss. 18, pp. 1757-1766
Closed Access | Times Cited: 1274
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
Immunopathology of Hyperinflammation in COVID-19
Joshua Gustine, Dennis Jones
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 4-17
Open Access | Times Cited: 480
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
Waleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 3, pp. e219-e234
Open Access | Times Cited: 360
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
Eduardo López‐Medina, Pío López, Isabel Cristina Hurtado, et al.
JAMA (2021) Vol. 325, Iss. 14, pp. 1426-1426
Open Access | Times Cited: 352
COVID-19 and Solid Organ Transplantation: A Review Article
Yorg Azzi, Rachel Bartash, Joseph R. Scalea, et al.
Transplantation (2020) Vol. 105, Iss. 1, pp. 37-55
Open Access | Times Cited: 286
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 272
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim, Min Ho An, Won Jun Kim, et al.
PLoS Medicine (2020) Vol. 17, Iss. 12, pp. e1003501-e1003501
Open Access | Times Cited: 203
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
COVID-19 in transplant recipients: The Spanish experience
Elisabeth Coll, Mario Fernández‐Ruiz, J. Emilio Sánchez-Álvarez, et al.
American Journal of Transplantation (2020) Vol. 21, Iss. 5, pp. 1825-1837
Open Access | Times Cited: 189
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e711-e720
Open Access | Times Cited: 175
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Jia-Tsrong Jan, Ting-Jen Rachel Cheng, Yu-Pu Juang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 5
Open Access | Times Cited: 169
Bots and Misinformation Spread on Social Media: Implications for COVID-19
McKenzie Himelein-Wachowiak, Salvatore Giorgi, Amanda Devoto, et al.
Journal of Medical Internet Research (2021) Vol. 23, Iss. 5, pp. e26933-e26933
Open Access | Times Cited: 150
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols
Paul Chen, Niklas Bobrovitz, Zahra Premji, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 147
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1059-1103
Open Access | Times Cited: 147
ESCMID COVID-19 living guidelines: drug treatment and clinical management
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 222-238
Open Access | Times Cited: 139
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
JAMA Network Open (2021) Vol. 4, Iss. 4, pp. e216468-e216468
Open Access | Times Cited: 127
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
Ryan Chang, Abrar Mamun, Abishai Dominic, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 114
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Zakariya Kashour, Muhammad Riaz, Musa A. Garbati, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 1, pp. 30-42
Open Access | Times Cited: 125
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot, Julien Andréani, Manon Boxberger, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101873-101873
Open Access | Times Cited: 99
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
José Miguel Vela
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 92
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
Pankaj Bansal, Amandeep Goyal, Austin Cusick, et al.
Annals of Medicine (2020) Vol. 53, Iss. 1, pp. 117-134
Open Access | Times Cited: 91
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Mathieu Gendrot, Julien Andréani, Priscilla Jardot, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5064-5064
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top